Oncology

  1. Erleada (apalutamide)
    Erleada (apalutamide)
    by Janssen Biotech
    for Prostate Cancer
    €17,400.00
  2. Nerlynx (neratinib)
    Nerlynx (neratinib)
    by Puma biotechnology
    for Breast Cancer
    €19,200.00
  3. Truxima (rituximab)
    Truxima (rituximab)
    by Teva Pharmaceuticals, Celltrion Healthcare Hungary Kft
    for Leukemia, Lymphoma, Rheumatoid Arthritis, Granulomatosis , Polyangiitis
    €760.39
  4. Aliqopa (copanlisib)
    Aliqopa (copanlisib)
    by Bayer
    for Lymphoma
    €6,925.91
  5. Verzenio/Verzenios (abemaciclib)
    Verzenio/Verzenios (abemaciclib)
    by Lilly
    for Breast Cancer
    €1,780.80
  6. Venclyxto/Venclexta (venetoclax)
    Venclyxto/Venclexta (venetoclax)
    by AbbVie Ltd
    for Leukemia
    €112.80
  7. Alecensa (alectinib)
    Alecensa (alectinib)
    by Roche Registration GmbH
    for Lung Cancer
    €5,491.50
  8. Alunbrig (brigatinib)
    Alunbrig (brigatinib)
    by ARIAD Pharmaceuticals, Inc.
    for Lung Cancer
    €7,035.00
  9. Bavencio (avelumab)
    Bavencio (avelumab)
    by Merck Serono Europe Limited
    for Urothelial Carcinoma, Skin Cancer
    €1,251.22
View as Grid List

Items 1-9 of 35

Page
per page
Set Descending Direction